Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Sees Large Decrease in Short Interest

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) was the recipient of a large decline in short interest in August. As of August 31st, there was short interest totaling 1,089 shares, a decline of 90.3% from the August 15th total of 11,255 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily volume of 12,371 shares, the days-to-cover ratio is presently 0.1 days.

Cuprina Holdings (Cayman) Stock Up 3.2%

NASDAQ CUPR traded up $0.10 during mid-day trading on Friday, reaching $3.10. The stock had a trading volume of 23,895 shares, compared to its average volume of 43,678. Cuprina Holdings has a 1 year low of $1.76 and a 1 year high of $14.80. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.35 and a quick ratio of 2.35. The company has a fifty day moving average price of $3.42 and a 200 day moving average price of $3.21.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded Cuprina Holdings (Cayman) from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 26th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Cuprina Holdings (Cayman) currently has an average rating of “Sell”.

Cuprina Holdings (Cayman) Company Profile

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.